|
化學名
Troglitazone |
[商品---廠商] [Rezulin-Parke Davis ] [Noscal,Prelay- 三共] |
|
|
藥理分類 |
New Oral hypoglycemia agents,Insulin sensitizer,Glitazone, Thiazolidinedione |
|
|
治療分類 |
Hypoglycemic agents |
|
|
作用機轉 |
Increased Insulin sensitivity;Decreased Insulin resistance PPARs [Peroxisomal-proliferator-activated receptors] activation |
|
|
適應症 |
Type 2 Diabetes |
一般劑量 |
|
400mg QD |
||
|
備註 |
•Syncratic hepatocellular injury 導致61人死亡 •FDA approve: 85.7.30. • FDA 89.3.21.下令市場回收• |
|
[89.6.29.]